speb/financial-data huggingface dataset:
Financial ratios for CCC — annual report dated 2023-12-31
Total revenue: 866378000
Gross profit: 636159000
Operating income: 58386000
Net income: -90071000
Capital expenditures: 55032000
Operating cash flow: 250033000
Depreciation & amortization: 135338000
Net tangible assets: -650493000
Owner earnings: -9765000
Capex to operating income (%): 94.25547220224027
Buffett classification: The Gruesome
Stock price: 11.39
Shares outstanding: 586940536
Book value: 1798861000
P/B ratio: 3.716380923840141
Market cap (USD): 6685252705.04
Debt to equity: 0.46311971853300504
Current ratio: 2.2889664959746776
Quick ratio: 2.2889664959746776
Interest coverage ratio: 0.9183509759818802
COGS to revenue (%): 26.572581482909307
R&D to revenue (%): 19.98042424899986
SG&A to revenue (%): 38.40067499405571
Free cash flow (dilution-adjusted): 50483000
Buyback yield (%): 4.913097746512706
Retained earnings: -1126467000
Receivables turnover: 8.317521576759502
Capitalized R&D asset: 278267190
ROCI (R&D-adjusted, %): 3.8241717898902405
Rosenberg metric: 0.4310097670062501
FCF margin (%): 5.8269023451657365
Revenue growth (%): 10.726591415659572
Rule of 40 score: 16.553493760825308
Financial ratios for CCC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.05
Shares outstanding: 586940536
Market cap (USD): 6485692922.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCC — annual report dated 2024-12-31
Total revenue: 944800000
Gross profit: 713803000
Operating income: 80105000
Net income: 31240000
Capital expenditures: 53012000
Operating cash flow: 283886000
Depreciation & amortization: 123676000
Net tangible assets: -354179000
Owner earnings: 101904000
Return on net tangible assets (%): -28.771892178813534
Capex to operating income (%): 66.17814118968853
Buffett classification: The Good
Stock price: 11.73
P/E ratio: 220.38452264020486
Shares outstanding: 586940536
Book value: 2019502000
P/B ratio: 3.409163490444674
Market cap (USD): 6884812487.280001
Debt to equity: 0.40799464422417014
Current ratio: 3.6465262260568565
Quick ratio: 3.6465262260568565
Effective tax rate (%): 29.503091573769012
Interest coverage ratio: 1.2398619366022783
COGS to revenue (%): 24.449301439458086
R&D to revenue (%): 21.32652413209145
SG&A to revenue (%): 38.14955546147333
Free cash flow (dilution-adjusted): 59836000
Buyback yield (%): 0
Retained earnings: -1095227000
Receivables turnover: 8.264448351571453
Capitalized R&D asset: 369269830
ROCI (R&D-adjusted, %): 3.07309221780645
Rosenberg metric: 0.4485344239945467
FCF margin (%): 6.333192209991532
Revenue growth (%): 9.051707222482564
Rule of 40 score: 15.384899432474096
Financial ratios for CCC — quarterly report dated 2024-12-31
Total revenue: 274465000
Gross profit: 185224000
Operating income: 21108000
Net income: 6260000
Capital expenditures: 7939000
Operating cash flow: 113645000
Depreciation & amortization: 31502000
Net tangible assets: -354179000
Owner earnings: 29823000
Return on net tangible assets (%): -8.420318539495565
Capex to operating income (%): 37.61133219632367
Buffett classification: The Good
Stock price: 11.73
P/E ratio: 274.95257537060706
Shares outstanding: 586940536
Book value: 2019502000
P/B ratio: 3.409163490444674
Market cap (USD): 6884812487.280001
Debt to equity: 0.40799464422417014
Current ratio: 3.6465262260568565
Quick ratio: 3.6465262260568565
Effective tax rate (%): 39.411536972512586
Interest coverage ratio: 1.391063661526295
COGS to revenue (%): 22.31249886142131
R&D to revenue (%): 19.397008726067074
SG&A to revenue (%): 33.860783706483524
Free cash flow (dilution-adjusted): 61889000
Buyback yield (%): 0
Retained earnings: -1095227000
Receivables turnover: 2.40082749451107
Capitalized R&D asset: 53238000
ROCI (R&D-adjusted, %): 1.8367022433078812
FCF margin (%): 22.548958883646367
Rule of 40 score: 22.548958883646367
Financial ratios for CCC — quarterly report dated 2025-03-31
Total revenue: 251565000
Gross profit: 184992000
Operating income: -10699000
Net income: -17421000
Capital expenditures: 14846000
Operating cash flow: 58492000
Depreciation & amortization: 36475000
Net tangible assets: -858323000
Owner earnings: 4208000
Buffett classification: The Gruesome
Stock price: 9.03
Shares outstanding: 586940536
Book value: 2177460000
P/B ratio: 2.434062182579703
Market cap (USD): 5300073040.08
Debt to equity: 0.48122491343124557
Current ratio: 1.5372505108464571
Quick ratio: 1.5372505108464571
Interest coverage ratio: -0.6321044546850998
COGS to revenue (%): 26.46353825055155
R&D to revenue (%): 24.55150756265776
SG&A to revenue (%): 45.87919623159025
Free cash flow (dilution-adjusted): -17402000
Buyback yield (%): 1.3636604524776337
Retained earnings: -1184922000
Receivables turnover: 2.319918478010273
Capitalized R&D asset: 97432460
ROCI (R&D-adjusted, %): 0.3621254436861616
Rosenberg metric: -0.004357789548818513
FCF margin (%): -6.91749647208475
Revenue growth (%): -8.343504636292423
Rule of 40 score: -15.261001108377172
Financial ratios for CCC — quarterly report dated 2025-06-30
Total revenue: 260451000
Gross profit: 194016000
Operating income: 24470000
Net income: 12960000
Capital expenditures: 15703000
Operating cash flow: 43056000
Depreciation & amortization: 36659000
Net tangible assets: -876553000
Owner earnings: 33916000
Return on net tangible assets (%): -3.869246925171667
Capex to operating income (%): 64.17245606865549
Buffett classification: The Good
Stock price: 9.41
P/E ratio: 3070.1003022568093
Shares outstanding: 586940536
Book value: 2136350000
P/B ratio: 2.585302241561542
Market cap (USD): 5523110443.76
Debt to equity: 0.5001301284901819
Current ratio: 1.3849656383095446
Quick ratio: 1.3849656383095446
Effective tax rate (%): -123.56391236846645
Interest coverage ratio: 1.3719443821484638
COGS to revenue (%): 25.507677067855372
R&D to revenue (%): 23.009702400835476
SG&A to revenue (%): 34.97970827526099
Free cash flow (dilution-adjusted): -18622000
Buyback yield (%): 1.814557232206507
Retained earnings: -1272181000
Receivables turnover: 1.5501467113446854
Capitalized R&D asset: 118878750
ROCI (R&D-adjusted, %): 0.748868598878161
Rosenberg metric: 0.14610689247607792
FCF margin (%): -7.149905356477802
Revenue growth (%): 3.5322878778844435
Rule of 40 score: -3.617617478593359
Financial ratios for CCC — annual report dated 2025-12-31
Total revenue: 1057001000
Gross profit: 776808000
Operating income: 93842000
Net income: 1688000
Capital expenditures: 60971000
Operating cash flow: 315479000
Depreciation & amortization: 150280000
Net tangible assets: -1179199000
Owner earnings: 90997000
Return on net tangible assets (%): -7.716848470868784
Capex to operating income (%): 64.97197416934848
Buffett classification: The Good
Stock price: 7.95
P/E ratio: 2764.323022037915
Shares outstanding: 586940536
Book value: 1787010000
P/B ratio: 2.611164605234442
Market cap (USD): 4666177261.2
Debt to equity: 0.7624036798898719
Current ratio: 1.431278163374266
Quick ratio: 1.431278163374266
Effective tax rate (%): 92.1594128849459
Interest coverage ratio: 1.3215880124494768
COGS to revenue (%): 26.508300370576755
R&D to revenue (%): 21.522780016291378
SG&A to revenue (%): 36.08539632412836
Free cash flow (dilution-adjusted): 79114000
Buyback yield (%): 12.870642634899651
Retained earnings: -1695057000
Receivables turnover: 6.205606763341748
Capitalized R&D asset: 419621290
ROCI (R&D-adjusted, %): 3.209416550659088
Rosenberg metric: 0.31269076345083946
FCF margin (%): 7.484761130784172
Revenue growth (%): 11.875635055038103
Rule of 40 score: 19.360396185822275
Financial ratios for CCC — quarterly report dated 2025-12-31
Total revenue: 307230000
Gross profit: 204827000
Operating income: 50096000
Net income: 8120000
Capital expenditures: 14287000
Operating cash flow: 119164000
Depreciation & amortization: 37263000
Net tangible assets: -1179199000
Owner earnings: 31096000
Return on net tangible assets (%): -2.6370442987146356
Capex to operating income (%): 28.51924305333759
Buffett classification: The Good
Stock price: 7.95
P/E ratio: 470.4281944954128
Shares outstanding: 586940536
Book value: 1787010000
P/B ratio: 2.611164605234442
Market cap (USD): 4666177261.2
Debt to equity: 0.7624036798898719
Current ratio: 1.431278163374266
Quick ratio: 1.431278163374266
Effective tax rate (%): 75.47124214596424
Interest coverage ratio: 2.7614795215258257
COGS to revenue (%): 23.773069036226932
R&D to revenue (%): 17.204374572795626
SG&A to revenue (%): 27.133743449532922
Free cash flow (dilution-adjusted): 75699000
Buyback yield (%): 8.31691507365061
Retained earnings: -1695057000
Receivables turnover: 1.8037339282569131
Capitalized R&D asset: 113391220
ROCI (R&D-adjusted, %): 1.2966670455201266
Rosenberg metric: 0.18039680288341203
FCF margin (%): 24.63919539107509
Revenue growth (%): 17.96076805233998
Rule of 40 score: 42.59996344341507
Financial ratios for CHAR — annual report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 84577274
Buffett classification: The Gruesome
Stock price: 9.96
Shares outstanding: 8546704
Book value: 84577274
P/B ratio: 1.006478074003662
Market cap (USD): 85125171.84
Debt to equity: 0
Current ratio: 9.203046298908006
Quick ratio: 9.203046298908006
Buyback yield (%): 0
Retained earnings: -1293097
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHAR — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -259769
Net income: 598362
Capital expenditures: 0
Operating cash flow: -171290
Owner earnings: 598362
Buffett classification: The Gruesome
Stock price: 9.96
P/E ratio: 35.565916552187474
Shares outstanding: 8546704
Market cap (USD): 85125171.84
Free cash flow (dilution-adjusted): -235640
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHAR — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -170252
Net income: 731257
Capital expenditures: 0
Operating cash flow: -261187
Net tangible assets: 85308531
Owner earnings: 731257
Return on net tangible assets (%): 0.8571909414311683
Buffett classification: The Gruesome
Stock price: 10.1
P/E ratio: 29.511413360829362
Shares outstanding: 8546704
Book value: 85308531
P/B ratio: 1.0118766480693473
Market cap (USD): 86321710.39999999
Debt to equity: 0
Current ratio: 5.572660192690014
Quick ratio: 5.572660192690014
Free cash flow (dilution-adjusted): -261187
Buyback yield (%): 0
Retained earnings: -1461042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.19567276684627627
Rule of 40 score: 0
Financial ratios for CHAR — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -127380
Net income: 778024
Capital expenditures: 0
Operating cash flow: -137601
Net tangible assets: 86086555
Owner earnings: 778024
Return on net tangible assets (%): 0.9037694678338563
Buffett classification: The Gruesome
Stock price: 10.28
P/E ratio: 49.02984930568111
Shares outstanding: 8546704
Book value: 86086555
P/B ratio: 1.020602080313238
Market cap (USD): 87860117.11999999
Debt to equity: 0
Current ratio: 19.950016829350385
Quick ratio: 19.950016829350385
Free cash flow (dilution-adjusted): -137601
Buyback yield (%): 0
Retained earnings: -1587646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.14510194641992727
Rule of 40 score: 0
Financial ratios for CHAR — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -109077
Net income: 806989
Capital expenditures: 0
Operating cash flow: -37856
Net tangible assets: 86893544
Owner earnings: 806989
Return on net tangible assets (%): 0.9287099626181664
Buffett classification: The Gruesome
Stock price: 10.36
P/E ratio: 30.379085057736273
Shares outstanding: 8546704
Book value: 86893544
P/B ratio: 1.018992313629192
Market cap (USD): 88543853.44
Debt to equity: 0
Current ratio: 1.0815562869122222
Quick ratio: 1.0815562869122222
Free cash flow (dilution-adjusted): -37856
Buyback yield (%): 0
Retained earnings: -1696629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.12312070956321602
Rule of 40 score: 0
Financial ratios for CHAR — annual report dated 2025-12-31
Total revenue: 0
Operating income: -595545
Net income: 2982042
Capital expenditures: 0
Operating cash flow: -543165
Net tangible assets: 87559316
Owner earnings: 2982042
Return on net tangible assets (%): 3.4057392590869484
Buffett classification: The Gruesome
Stock price: 10.45
P/E ratio: 29.95030143773964
Shares outstanding: 8546704
Book value: 87559316
P/B ratio: 1.0200291742799816
Market cap (USD): 89313056.8
Debt to equity: 0.0011521446786998655
Current ratio: 0.06695448042396276
Quick ratio: 0.06695448042396276
Free cash flow (dilution-adjusted): -543165
Buyback yield (%): 0
Retained earnings: -1885464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6672076671526365
Rule of 40 score: 0
Financial ratios for CHAR — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -188836
Net income: 665772
Capital expenditures: 0
Operating cash flow: -106521
Net tangible assets: 87559316
Owner earnings: 665772
Return on net tangible assets (%): 0.7603668352091741
Buffett classification: The Gruesome
Stock price: 10.45
P/E ratio: 29.95030143773964
Shares outstanding: 8546704
Book value: 87559316
P/B ratio: 1.0200291742799816
Market cap (USD): 89313056.8
Debt to equity: 0.0011521446786998655
Current ratio: 0.06695448042396276
Quick ratio: 0.06695448042396276
Free cash flow (dilution-adjusted): -106521
Buyback yield (%): 0
Retained earnings: -1885464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21155886966465215
Rule of 40 score: 0
Financial ratios for CLIR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.8
Shares outstanding: 6307455
Market cap (USD): 87042879
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLIR — annual report dated 2022-12-31
Total revenue: 374000
Gross profit: 116000
Operating income: -5885000
Net income: -5758000
Capital expenditures: 29000
Operating cash flow: -4992000
Depreciation & amortization: 292000
Net tangible assets: 8754000
Owner earnings: -5495000
Return on net tangible assets (%): -62.771304546493035
Buffett classification: The Gruesome
Stock price: 5.4
Shares outstanding: 6307455
Book value: 9552000
P/B ratio: 3.5657722989949754
Market cap (USD): 34060257
Debt to equity: 0.037583752093802346
Current ratio: 8.485614646904969
Quick ratio: 8.485614646904969
COGS to revenue (%): 68.98395721925134
R&D to revenue (%): 135.02673796791444
SG&A to revenue (%): 1531.5508021390376
Free cash flow (dilution-adjusted): -5529000
Buyback yield (%): 0
Retained earnings: -88523000
Receivables turnover: 3.7777777777777777
Capitalized R&D asset: 505000
ROCI (R&D-adjusted, %): -53.95636811566015
FCF margin (%): -1478.3422459893047
Rule of 40 score: -1478.3422459893047
Financial ratios for CLIR — annual report dated 2023-12-31
Total revenue: 2403000
Gross profit: 817000
Operating income: -5726000
Net income: -5194000
Capital expenditures: 5000
Operating cash flow: -3233000
Depreciation & amortization: 424000
Net tangible assets: 4356000
Owner earnings: -4775000
Return on net tangible assets (%): -109.61891643709825
Buffett classification: The Gruesome
Stock price: 11.1
Shares outstanding: 6307455
Book value: 5192000
P/B ratio: 13.484736228813558
Market cap (USD): 70012750.5
Debt to equity: 0.04680277349768875
Current ratio: 2.8851950354609928
Quick ratio: 2.8851950354609928
COGS to revenue (%): 66.00083229296713
R&D to revenue (%): 30.753225135247607
SG&A to revenue (%): 252.14315439034542
Free cash flow (dilution-adjusted): -4047000
Buyback yield (%): 0
Retained earnings: -93717000
Receivables turnover: 5.058947368421053
Capitalized R&D asset: 1077350
ROCI (R&D-adjusted, %): -83.85923240728522
Rosenberg metric: 1.388118811881188
FCF margin (%): -168.41448189762795
Revenue growth (%): 542.5133689839572
Rule of 40 score: 374.0988870863292
Financial ratios for CLIR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.5
Shares outstanding: 6307455
Market cap (USD): 53613367.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLIR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.4
Shares outstanding: 6307455
Market cap (USD): 90827352
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLIR — annual report dated 2024-12-31
Total revenue: 3596000
Gross profit: 1118000
Operating income: -5824000
Net income: -5299000
Capital expenditures: 39000
Operating cash flow: -4373000
Depreciation & amortization: 272000
Net tangible assets: 12934000
Owner earnings: -5066000
Return on net tangible assets (%): -39.168084119375294
Buffett classification: The Gruesome
Stock price: 14.4
Shares outstanding: 6307455
Book value: 13764000
P/B ratio: 6.598906713164777
Market cap (USD): 90827352
Debt to equity: 0.013658820110433014
Current ratio: 6.321562110511009
Quick ratio: 6.321562110511009
COGS to revenue (%): 68.9098998887653
R&D to revenue (%): 40.906562847608456
SG&A to revenue (%): 170.60622914349278
Free cash flow (dilution-adjusted): -5119000
Buyback yield (%): 0
Retained earnings: -99016000
Receivables turnover: 21.793939393939393
Capitalized R&D asset: 2132780
ROCI (R&D-adjusted, %): -32.84242506767738
Rosenberg metric: 0.40730717185385656
FCF margin (%): -142.35261401557287
Revenue growth (%): 49.64627548897212
Rule of 40 score: -92.70633852660075
Financial ratios for CLIR — quarterly report dated 2025-03-31
Total revenue: 401000
Gross profit: 196000
Operating income: -2209000
Net income: -2076000
Capital expenditures: 4000
Operating cash flow: -1111000
Depreciation & amortization: 69000
Net tangible assets: 11216000
Owner earnings: -2011000
Return on net tangible assets (%): -17.92974322396576
Buffett classification: The Gruesome
Stock price: 7.5
Shares outstanding: 6307455
Book value: 12040000
P/B ratio: 3.9290625
Market cap (USD): 47305912.5
Debt to equity: 0.013787375415282393
Current ratio: 5.632303839732888
Quick ratio: 5.632303839732888
COGS to revenue (%): 51.12219451371571
R&D to revenue (%): 111.4713216957606
SG&A to revenue (%): 500.2493765586035
Free cash flow (dilution-adjusted): -1197000
Buyback yield (%): 0
Retained earnings: -101092000
Receivables turnover: 1.407017543859649
Capitalized R&D asset: 447000
ROCI (R&D-adjusted, %): -15.184743742550655
FCF margin (%): -298.50374064837905
Rule of 40 score: -298.50374064837905
Financial ratios for CLIR — quarterly report dated 2025-06-30
Total revenue: 133000
Gross profit: 55000
Operating income: -1795000
Net income: -1680000
Capital expenditures: 0
Operating cash flow: -511000
Depreciation & amortization: 115000
Net tangible assets: 9616000
Owner earnings: -1565000
Return on net tangible assets (%): -16.27495840266223
Buffett classification: The Gruesome
Stock price: 5.6
Shares outstanding: 6307455
Book value: 10414000
P/B ratio: 3.3917560975609757
Market cap (USD): 35321748
Debt to equity: 0.01997311311695794
Current ratio: 3.560777957860616
Quick ratio: 3.560777957860616
COGS to revenue (%): 58.64661654135338
R&D to revenue (%): 185.71428571428572
SG&A to revenue (%): 1237.593984962406
Free cash flow (dilution-adjusted): -578000
Buyback yield (%): 0
Retained earnings: -102772000
Receivables turnover: 0.4539249146757679
Capitalized R&D asset: 546490
ROCI (R&D-adjusted, %): -16.06550440055775
Rosenberg metric: -0.31543624161073824
FCF margin (%): -434.5864661654136
Revenue growth (%): -66.83291770573567
Rule of 40 score: -501.41938387114925
Financial ratios for CLIR — quarterly report dated 2025-09-30
Total revenue: 1029000
Gross profit: 368000
Operating income: -1534000
Net income: -1429000
Capital expenditures: 0
Operating cash flow: -1831000
Depreciation & amortization: 69000
Net tangible assets: 8300000
Owner earnings: -1360000
Return on net tangible assets (%): -16.3855421686747
Buffett classification: The Gruesome
Stock price: 7.7
Shares outstanding: 6307455
Book value: 9078000
P/B ratio: 5.35001140118969
Market cap (USD): 48567403.5
Debt to equity: 0.020378938092090768
Current ratio: 3.282839575181666
Quick ratio: 3.282839575181666
COGS to revenue (%): 64.23712342079689
R&D to revenue (%): 30.12633624878523
SG&A to revenue (%): 175.70456754130223
Free cash flow (dilution-adjusted): -2619000
Buyback yield (%): 0
Retained earnings: -104201000
Receivables turnover: 1.227923627684964
Capitalized R&D asset: 623000
ROCI (R&D-adjusted, %): -15.917755991285404
Rosenberg metric: 1.2672064777327936
FCF margin (%): -254.5189504373178
Revenue growth (%): 673.6842105263157
Rule of 40 score: 419.1652600889979
Financial ratios for CLIR — quarterly report dated 2025-12-31
Total revenue: 3671000
Gross profit: 805000
Operating income: -397000
Net income: -311000
Capital expenditures: 0
Operating cash flow: -1283000
Depreciation & amortization: 192000
Net tangible assets: 8770000
Owner earnings: -119000
Return on net tangible assets (%): -1.3568985176738884
Buffett classification: The Gruesome
Stock price: 5.6
Shares outstanding: 6307455
Book value: 9530000
P/B ratio: 3.706374396642182
Market cap (USD): 35321748
Debt to equity: 0.017103882476390345
Current ratio: 4.344427244582043
Quick ratio: 4.344427244582043
COGS to revenue (%): 78.07137019885589
R&D to revenue (%): 11.386543176246255
SG&A to revenue (%): 33.04276763824571
Free cash flow (dilution-adjusted): -1336000
Buyback yield (%): 0
Retained earnings: -104512000
Receivables turnover: 2.699264705882353
Capitalized R&D asset: 707210
ROCI (R&D-adjusted, %): -2.950250431619697
Rosenberg metric: 1.4096774193548387
FCF margin (%): -36.393353309724866
Revenue growth (%): 256.75413022351796
Rule of 40 score: 220.3607769137931
Financial ratios for CLIR — annual report dated 2025-12-31
Total revenue: 5234000
Gross profit: 1424000
Operating income: -5935000
Net income: -5496000
Capital expenditures: 4000
Operating cash flow: -4736000
Depreciation & amortization: 277000
Net tangible assets: 8770000
Owner earnings: -5223000
Return on net tangible assets (%): -59.55530216647662
Buffett classification: The Gruesome
Stock price: 5.6
Shares outstanding: 6307455
Book value: 9530000
P/B ratio: 3.706374396642182
Market cap (USD): 35321748
Debt to equity: 0.017103882476390345
Current ratio: 4.344427244582043
Quick ratio: 4.344427244582043
COGS to revenue (%): 72.79327474207108
R&D to revenue (%): 27.16851356515094
SG&A to revenue (%): 127.49331295376385
Free cash flow (dilution-adjusted): -5730000
Buyback yield (%): 0
Retained earnings: -104512000
Receivables turnover: 3.848529411764706
Capitalized R&D asset: 2651440
ROCI (R&D-adjusted, %): -46.72976041574818
Rosenberg metric: 0.2080217539089055
FCF margin (%): -109.47649980894154
Revenue growth (%): 45.550611790878754
Rule of 40 score: -63.925888018062786
Financial ratios for CMG.AX — annual report dated 2023-06-30
Operating income: -986992.7152317881
Net income: -951168.2119205298
Capital expenditures: 498156.2913907285
Net tangible assets: 2250689.40397351
Owner earnings: -1449324.5033112583
Return on net tangible assets (%): -64.39469172212429
Buffett classification: The Gruesome
Stock price: 0.1456953642384106
Shares outstanding: 119574349
Book value: 2250689.40397351
P/B ratio: 7.740485337678726
Market cap (USD): 17421428.331125826
Debt to equity: 0
Current ratio: 18.798178852021486
Quick ratio: 18.798178852021486
Free cash flow (dilution-adjusted): -1332759.6026490065
Buyback yield (%): 1.2748933757903667
Retained earnings: -1571741.059602649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.85290629125851
Rule of 40 score: 0
Financial ratios for CMG.AX — annual report dated 2024-06-30
Operating income: -1257106
Net income: -1197938.6666666667
Capital expenditures: 1006515.3333333334
Net tangible assets: 2154226
Owner earnings: -2204454
Return on net tangible assets (%): -102.3316030908549
Buffett classification: The Gruesome
Stock price: 0.09333333333333334
Shares outstanding: 119574349
Book value: 2154226
P/B ratio: 5.180641480203718
Market cap (USD): 11160272.573333334
Debt to equity: 0
Current ratio: 2.570178858002035
Quick ratio: 2.570178858002035
Interest coverage ratio: -1984.9042105263156
Free cash flow (dilution-adjusted): -1935301.3333333333
Buyback yield (%): 0.41990611213781304
Retained earnings: -2780158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -58.35534433248879
Rule of 40 score: 0
Financial ratios for CNMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 136.67
Shares outstanding: 30109194
Market cap (USD): 4115023543.9799995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNMD — annual report dated 2022-12-31
Total revenue: 1045472000
Gross profit: 571245000
Operating income: 70054000
Net income: -80582000
Capital expenditures: 21785000
Operating cash flow: 33365000
Depreciation & amortization: 69519000
Net tangible assets: -751683000
Owner earnings: -32848000
Capex to operating income (%): 31.097439118394384
Buffett classification: The Good
Stock price: 86.12
Shares outstanding: 30109194
Book value: 745545000
P/B ratio: 3.4779976893145284
Market cap (USD): 2593003787.28
Debt to equity: 1.4148334439906378
Current ratio: 1.959946316329008
Quick ratio: 0.8393334052712509
Interest coverage ratio: 2.4235945338176785
COGS to revenue (%): 45.36008616203973
R&D to revenue (%): 4.510116005019742
SG&A to revenue (%): 43.42909231428484
Free cash flow (dilution-adjusted): -10149000
Buyback yield (%): 0
Retained earnings: 412631000
Inventory turnover: 1.4270191381800674
Receivables turnover: 5.4638062139068175
Capitalized R&D asset: 47152000
ROCI (R&D-adjusted, %): 4.9550367673863915
FCF margin (%): -0.9707577056104801
Rule of 40 score: -0.9707577056104801
Financial ratios for CNMD — annual report dated 2023-12-31
Total revenue: 1244744000
Gross profit: 676245000
Operating income: 120603000
Net income: 64459000
Capital expenditures: 19032000
Operating cash flow: 125348000
Depreciation & amortization: 71874000
Net tangible assets: -622106000
Owner earnings: 117301000
Return on net tangible assets (%): -18.855468360697373
Capex to operating income (%): 15.780701972587746
Buffett classification: The Great
Stock price: 107.19
P/E ratio: 50.06910601870956
Shares outstanding: 30109194
Book value: 834222000
P/B ratio: 3.8687597604234845
Market cap (USD): 3227404504.86
Debt to equity: 1.1673727137380696
Current ratio: 1.9813052531305415
Quick ratio: 0.9568627324774964
Effective tax rate (%): 20.251645469391793
Interest coverage ratio: 3.0321307353865494
COGS to revenue (%): 45.671961463561985
R&D to revenue (%): 4.22592918704569
SG&A to revenue (%): 40.41312912534625
Free cash flow (dilution-adjusted): 82059000
Buyback yield (%): 0
Retained earnings: 452531000
Inventory turnover: 1.7859130948341941
Receivables turnover: 5.137647092814483
Capitalized R&D asset: 84193840
ROCI (R&D-adjusted, %): 6.749680367562416
Rosenberg metric: 2.2268408551068886
FCF margin (%): 6.592439891254748
Revenue growth (%): 19.060481772826055
Rule of 40 score: 25.652921664080804
Financial ratios for CNMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.7
Shares outstanding: 30109194
Market cap (USD): 2038392433.8000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNMD — annual report dated 2024-12-31
Total revenue: 1307015000
Gross profit: 733032000
Operating income: 200326000
Net income: 132423000
Capital expenditures: 13084000
Operating cash flow: 166968000
Depreciation & amortization: 71857000
Net tangible assets: -460340000
Owner earnings: 191196000
Return on net tangible assets (%): -41.53364904201243
Capex to operating income (%): 6.531353893154159
Buffett classification: The Great
Stock price: 67.7
P/E ratio: 15.393039228834871
Shares outstanding: 30109194
Book value: 962681000
P/B ratio: 2.1174121373539108
Market cap (USD): 2038392433.8000002
Debt to equity: 0.9408942318379608
Current ratio: 2.301107395822098
Quick ratio: 1.0544996943875167
Effective tax rate (%): 18.7733470732201
Interest coverage ratio: 5.3711022334236
COGS to revenue (%): 43.91556332559305
R&D to revenue (%): 4.164145017463457
SG&A to revenue (%): 36.59330612119983
Free cash flow (dilution-adjusted): 128326000
Buyback yield (%): 0
Retained earnings: 560277000
Inventory turnover: 1.655470279967351
Receivables turnover: 5.497827394598142
Capitalized R&D asset: 105229500
ROCI (R&D-adjusted, %): 9.532378667350413
Rosenberg metric: 1.079559712558458
FCF margin (%): 9.818249981828824
Revenue growth (%): 5.0027154177887185
Rule of 40 score: 14.820965399617542
Financial ratios for CNMD — quarterly report dated 2025-03-31
Total revenue: 321256000
Gross profit: 177752000
Operating income: 15958000
Net income: 6036000
Capital expenditures: 3779000
Operating cash flow: 41534000
Depreciation & amortization: 18253000
Net tangible assets: -437894000
Owner earnings: 20510000
Return on net tangible assets (%): -4.683781919825345
Capex to operating income (%): 23.68091239503697
Buffett classification: The Great
Stock price: 59.94
P/E ratio: 74.74921671471172
Shares outstanding: 30109194
Book value: 977636000
P/B ratio: 1.8460296964923548
Market cap (USD): 1804745088.36
Debt to equity: 0.9125656174690785
Current ratio: 2.2567703109327986
Quick ratio: 1.0041321146538207
Effective tax rate (%): 21.32429614181439
Interest coverage ratio: 1.9258991069273472
COGS to revenue (%): 44.66967153920861
R&D to revenue (%): 4.030119281818861
SG&A to revenue (%): 46.3328311377842
Free cash flow (dilution-adjusted): 23892000
Buyback yield (%): 0
Retained earnings: 560127000
Inventory turnover: 0.40459904928922247
Receivables turnover: 1.4527399180602159
Capitalized R&D asset: 12947000
ROCI (R&D-adjusted, %): 1.2128015604248685
FCF margin (%): 7.437059541300396
Rule of 40 score: 7.437059541300396
Financial ratios for CNMD — quarterly report dated 2025-06-30
Total revenue: 342345000
Gross profit: 188320000
Operating income: 38161000
Net income: 21421000
Capital expenditures: 5729000
Operating cash flow: 29134000
Depreciation & amortization: 18571000
Net tangible assets: -405873000
Owner earnings: 34263000
Return on net tangible assets (%): -8.441803224161253
Capex to operating income (%): 15.012709310552658
Buffett classification: The Great
Stock price: 51.88
P/E ratio: 18.230532943373326
Shares outstanding: 30109194
Book value: 1002870000
P/B ratio: 1.5575946879655391
Market cap (USD): 1562064984.72
Debt to equity: 0.8793014049677426
Current ratio: 2.2309878645222123
Quick ratio: 1.0023402682150877
Effective tax rate (%): 28.40335572712992
Interest coverage ratio: 4.8774284253578735
COGS to revenue (%): 44.991163884385635
R&D to revenue (%): 4.129752150608304
SG&A to revenue (%): 39.732141553111624
Free cash flow (dilution-adjusted): 18502000
Buyback yield (%): 0
Retained earnings: 575359000
Inventory turnover: 0.425187438578669
Receivables turnover: 1.4620880810427592
Capitalized R&D asset: 22812490
ROCI (R&D-adjusted, %): 2.104161788781438
Rosenberg metric: 0.8162508689271646
FCF margin (%): 5.404489623041084
Revenue growth (%): 6.564546654381552
Rule of 40 score: 11.969036277422635
Financial ratios for CNMD — quarterly report dated 2025-09-30
Total revenue: 337926000
Gross profit: 166119000
Operating income: 11879000
Net income: 2859000
Capital expenditures: 5187000
Operating cash flow: 53686000
Depreciation & amortization: 18607000
Net tangible assets: -391760000
Owner earnings: 16279000
Return on net tangible assets (%): -4.155350214416989
Capex to operating income (%): 43.6652916912198
Buffett classification: The Good
Stock price: 47.03
P/E ratio: 46.70917646853147
Shares outstanding: 30109194
Book value: 1008263000
P/B ratio: 1.4044305839051916
Market cap (USD): 1416035393.82
Debt to equity: 0.8467562530807934
Current ratio: 2.1040994728295925
Quick ratio: 0.94631060155895
Effective tax rate (%): 33.09150479756611
Interest coverage ratio: 1.5617933210623192
COGS to revenue (%): 50.84160437492232
R&D to revenue (%): 4.113622509070033
SG&A to revenue (%): 41.529506459994195
Free cash flow (dilution-adjusted): 43913000
Buyback yield (%): 0
Retained earnings: 572027000
Inventory turnover: 0.4715373742641106
Receivables turnover: 1.502273909390379
Capitalized R&D asset: 27645970
ROCI (R&D-adjusted, %): 0.595351862309804
Rosenberg metric: -1.5703069741123215
FCF margin (%): 12.994856862153254
Revenue growth (%): -1.290803137186172
Rule of 40 score: 11.704053724967082
Financial ratios for CNMD — quarterly report dated 2025-12-31
Total revenue: 373198000
Gross profit: 218285000
Operating income: 36624000
Net income: 16739000
Capital expenditures: 5111000
Operating cash flow: 46335000
Depreciation & amortization: 18850000
Net tangible assets: -355965000
Owner earnings: 30478000
Return on net tangible assets (%): -8.562077732361328
Capex to operating income (%): 13.955329838357361
Buffett classification: The Great
Stock price: 40.6
P/E ratio: 25.978817902454576
Shares outstanding: 30109194
Book value: 1033097000
P/B ratio: 1.1832705703336666
Market cap (USD): 1222433276.4
Debt to equity: 0.8081932287094048
Current ratio: 2.135785500934799
Quick ratio: 1.0072212823092868
Effective tax rate (%): 42.7785184425529
Interest coverage ratio: 4.968660968660969
COGS to revenue (%): 41.509600801719195
R&D to revenue (%): 3.992250762329916
SG&A to revenue (%): 44.68459102138811
Free cash flow (dilution-adjusted): 36253000
Buyback yield (%): 0
Retained earnings: 588766000
Inventory turnover: 0.43570697297662175
Receivables turnover: 1.5058628898841948
Capitalized R&D asset: 28878210
ROCI (R&D-adjusted, %): 1.8244060070073398
Rosenberg metric: 3.752679663333573
FCF margin (%): 9.714146378062047
Revenue growth (%): 10.437788154803123
Rule of 40 score: 20.15193453286517
Financial ratios for CNMD — annual report dated 2025-12-31
Total revenue: 1374724000
Gross profit: 750475000
Operating income: 102622000
Net income: 47055000
Capital expenditures: 19806000
Operating cash flow: 170689000
Depreciation & amortization: 74281000
Net tangible assets: -355965000
Owner earnings: 101530000
Return on net tangible assets (%): -28.522467096484206
Capex to operating income (%): 19.29995517530354
Buffett classification: The Great
Stock price: 40.6
P/E ratio: 25.978817902454576
Shares outstanding: 30109194
Book value: 1033097000
P/B ratio: 1.1832705703336666
Market cap (USD): 1222433276.4
Debt to equity: 0.8081932287094048
Current ratio: 2.135785500934799
Quick ratio: 1.0072212823092868
Effective tax rate (%): 33.83438558994333
Interest coverage ratio: 3.3011226557725095
COGS to revenue (%): 45.40904210590635
R&D to revenue (%): 4.065106886909663
SG&A to revenue (%): 43.060934413016724
Free cash flow (dilution-adjusted): 122560000
Buyback yield (%): 0
Retained earnings: 588766000
Inventory turnover: 1.755757374614675
Receivables turnover: 5.547044344913853
Capitalized R&D asset: 109708080
ROCI (R&D-adjusted, %): 4.914224193206458
Rosenberg metric: 0.3204902068864146
FCF margin (%): 8.915244078084038
Revenue growth (%): 5.180430216944718
Rule of 40 score: 14.095674295028756
Financial ratios for CRRX.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.377952755905511
Shares outstanding: 63447016
Market cap (USD): 277768038.5511811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRRX.TO — annual report dated 2022-12-31
Total revenue: 280681617.6470588
Gross profit: 80833823.52941176
Operating income: 5612500
Net income: -25259558.82352941
Capital expenditures: 7381617.647058823
Operating cash flow: 16421323.529411763
Depreciation & amortization: 14753676.470588233
Net tangible assets: -43021323.52941176
Owner earnings: -17887500
Capex to operating income (%): 131.52102711908816
Buffett classification: The Gruesome
Stock price: 1.838235294117647
Shares outstanding: 63447016
Book value: 47394852.941176444
P/B ratio: 2.460827218145431
Market cap (USD): 116630544.11764705
Debt to equity: 2.09789472051135
Current ratio: 1.3958395291686885
Quick ratio: 1.0780440465196364
Interest coverage ratio: 0.5014782208790487
COGS to revenue (%): 71.20088440167974
SG&A to revenue (%): 9.020058837860566
Free cash flow (dilution-adjusted): 3052205.882352941
Buyback yield (%): 0
Retained earnings: -203884558.8235294
Inventory turnover: 13.386839383342364
Receivables turnover: 10.24467942352594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8041744747019655
FCF margin (%): 1.0874263544365477
Rule of 40 score: 1.0874263544365477
Financial ratios for CRRX.TO — annual report dated 2023-12-31
Total revenue: 280868181.8181818
Gross profit: 79316666.66666666
Operating income: 5474242.424242424
Net income: -4094696.9696969697
Capital expenditures: 3552272.727272727
Operating cash flow: 20738636.363636363
Depreciation & amortization: 15133333.333333332
Net tangible assets: -24861363.636363637
Owner earnings: 7486363.636363637
Capex to operating income (%): 64.89067257127041
Buffett classification: The Good
Stock price: 1.1893939393939394
Shares outstanding: 63447016
Book value: 61762121.21212122
P/B ratio: 1.221841070578711
Market cap (USD): 75463496.30303031
Debt to equity: 1.2004023256384464
Current ratio: 1.0474627295873433
Quick ratio: 0.7327259043379398
Interest coverage ratio: 0.5063770147161878
COGS to revenue (%): 71.76018082460769
SG&A to revenue (%): 8.270352208789845
Free cash flow (dilution-adjusted): 13037121.212121211
Buyback yield (%): 0.05621823067126938
Retained earnings: -214157575.75757575
Inventory turnover: 13.535894174510304
Receivables turnover: 10.272533318555874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.2645357758315425
FCF margin (%): 4.6417223651772375
Revenue growth (%): 0.0664682542045278
Rule of 40 score: 4.7081906193817655
Financial ratios for CRRX.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3407407407407408
Shares outstanding: 63447016
Market cap (USD): 85065999.22962964
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRRX.TO — annual report dated 2024-12-31
Total revenue: 256443356.64335665
Gross profit: 75566433.56643356
Operating income: 5213286.713286714
Net income: -3147552.4475524477
Capital expenditures: 3770629.3706293707
Operating cash flow: 26567132.86713287
Depreciation & amortization: 13419580.41958042
Net tangible assets: -14046853.146853147
Owner earnings: 6501398.601398602
Capex to operating income (%): 72.32729711602951
Buffett classification: The Good
Stock price: 1.4055944055944054
Shares outstanding: 63447016
Book value: 58900699.30069929
P/B ratio: 1.5140867901410455
Market cap (USD): 89180770.74125873
Debt to equity: 0.9810395592914471
Current ratio: 0.9925639310849973
Quick ratio: 0.7111875417980319
Interest coverage ratio: 0.8119146155521673
COGS to revenue (%): 70.5328948444837
SG&A to revenue (%): 8.931210698255317
Free cash flow (dilution-adjusted): 18339160.839160837
Buyback yield (%): 0.6280948857966264
Retained earnings: -200831468.53146854
Inventory turnover: 14.63720219568785
Receivables turnover: 11.062929890189453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.638040015926737
FCF margin (%): 7.151349553057695
Revenue growth (%): -8.696188018419408
Rule of 40 score: -1.5448384653617122
Financial ratios for CRRX.TO — quarterly report dated 2024-12-31
Total revenue: 64462237.762237765
Gross profit: 19119580.41958042
Operating income: 322377.6223776224
Net income: -1569930.06993007
Capital expenditures: 1883916.083916084
Operating cash flow: 5874825.174825175
Depreciation & amortization: 3345454.5454545454
Net tangible assets: -14046853.146853147
Owner earnings: -108391.60839160858
Capex to operating income (%): 584.3817787418654
Buffett classification: The Gruesome
Stock price: 1.4055944055944054
Shares outstanding: 63447016
Book value: 58900699.30069929
P/B ratio: 1.5140867901410455
Market cap (USD): 89180770.74125873
Debt to equity: 0.9810395592914471
Interest coverage ratio: 0.19476130122517954
COGS to revenue (%): 70.33987481151213
SG&A to revenue (%): 10.670311669432962
Free cash flow (dilution-adjusted): 1837762.237762238
Buyback yield (%): 0.19289805481394517
Retained earnings: -200831468.53146854
Inventory turnover: 3.669288665044423
Receivables turnover: 2.7808917581754558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2062289185731285
FCF margin (%): 2.850912877924952
Rule of 40 score: 2.850912877924952
Financial ratios for CRRX.TO — quarterly report dated 2025-03-31
Total revenue: 62622377.62237763
Gross profit: 18596503.4965035
Operating income: 1817482.5174825175
Net income: 158741.25874125876
Capital expenditures: 1155244.7552447552
Operating cash flow: 5156643.356643357
Depreciation & amortization: 3327272.7272727275
Net tangible assets: -11028671.328671329
Owner earnings: 2330769.230769231
Return on net tangible assets (%): -21.13372645995815
Capex to operating income (%): 63.56290881108117
Buffett classification: The Good
Stock price: 1.8391608391608392
P/E ratio: 183.7727445814978
Shares outstanding: 63447016
Book value: 60418881.11888112
P/B ratio: 1.9313377710390167
Market cap (USD): 116689267.18881118
Debt to equity: 0.9547101239597681
Current ratio: 1.0681993722371035
Quick ratio: 0.7620910091863732
Effective tax rate (%): 0
Interest coverage ratio: 1.5075406032482597
COGS to revenue (%): 70.30374092685649
SG&A to revenue (%): 9.335566722501396
Free cash flow (dilution-adjusted): 3595104.8951048953
Buyback yield (%): 0.22593025904411762
Retained earnings: -200672727.27272728
Inventory turnover: 3.3798786707467654
Receivables turnover: 2.753097426753159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.597791739926965
FCF margin (%): 5.740926856504746
Revenue growth (%): -2.8541673446805715
Rule of 40 score: 2.8867595118241747
Financial ratios for CRRX.TO — quarterly report dated 2025-06-30
Total revenue: 66708029.197080284
Gross profit: 19797080.2919708
Operating income: 2137226.2773722624
Net income: 409489.05109489046
Capital expenditures: 1227737.226277372
Operating cash flow: 2751094.890510949
Depreciation & amortization: 3316058.3941605836
Net tangible assets: -10001459.854014598
Owner earnings: 2497810.2189781023
Return on net tangible assets (%): -24.974456283754197
Capex to operating income (%): 57.44535519125683
Buffett classification: The Good
Stock price: 2.0802919708029197
P/E ratio: 80.58110320855616
Shares outstanding: 63447016
Book value: 63464233.57664232
P/B ratio: 2.0797275964391697
Market cap (USD): 131988317.95620438
Debt to equity: 0.9415959331079062
Current ratio: 1.0817657874266318
Quick ratio: 0.7798069443462273
Effective tax rate (%): 0
Interest coverage ratio: 1.6721873215305538
COGS to revenue (%): 70.32388663967612
SG&A to revenue (%): 8.913447860816282
Free cash flow (dilution-adjusted): 813138.6861313869
Buyback yield (%): 0.2975268842029724
Retained earnings: -209051824.81751823
Inventory turnover: 3.762822014051522
Receivables turnover: 2.832481016581435
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8102456938656906
FCF margin (%): 1.218951745267535
Revenue growth (%): 6.524267729564266
Rule of 40 score: 7.7432194748318
Financial ratios for CRRX.TO — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.5611510791366907
Shares outstanding: 63447016
Market cap (USD): 162497393.4964029
Quick ratio: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRRX.TO — annual report dated 2025-12-31
Total revenue: 270248905.109489
Gross profit: 80994890.5109489
Operating income: 8673722.627737226
Net income: 19070802.91970803
Capital expenditures: 4048175.1824817513
Operating cash flow: 22491240.875912406
Depreciation & amortization: 13381751.824817518
Net tangible assets: 7740875.912408759
Owner earnings: 28404379.562043793
Return on net tangible assets (%): 366.94012258368696
Capex to operating income (%): 46.67171589665909
Buffett classification: The Good
Stock price: 2.7591240875912404
P/E ratio: 9.179382266620735
Shares outstanding: 63447016
Book value: 79929927.00729926
P/B ratio: 2.1901457524839274
Market cap (USD): 175058190.13138682
Debt to equity: 0.7116178404441847
Current ratio: 1.063173258451922
Quick ratio: 0.7848269953833706
Effective tax rate (%): -679.2126453921861
Interest coverage ratio: 1.7362653419053187
COGS to revenue (%): 70.02952131179421
SG&A to revenue (%): 9.24478920486926
Free cash flow (dilution-adjusted): 14452554.744525546
Buyback yield (%): 0.93357903912777
Retained earnings: -192392700.729927
Inventory turnover: 14.777885437446566
Receivables turnover: 11.25318379380566
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.604822303989685
FCF margin (%): 5.347868010295997
Revenue growth (%): 5.383468944891467
Rule of 40 score: 10.731336955187464
Financial ratios for CRRX.TO — quarterly report dated 2025-12-31
Total revenue: 70132116.78832117
Gross profit: 21242335.766423356
Operating income: 2191240.875912409
Net income: 17364233.576642334
Capital expenditures: 967883.2116788321
Operating cash flow: 7002919.708029197
Depreciation & amortization: 3316058.3941605836
Net tangible assets: 7740875.912408759
Owner earnings: 19712408.759124085
Return on net tangible assets (%): 254.6534653465346
Capex to operating income (%): 44.1705529646902
Buffett classification: The Good
Stock price: 2.7591240875912404
P/E ratio: 9.762082402038741
Shares outstanding: 63447016
Book value: 79929927.00729926
P/B ratio: 2.1901457524839274
Market cap (USD): 175058190.13138682
Debt to equity: 0.7116178404441847
Current ratio: 1.063173258451922
Quick ratio: 0.7848269953833706
Effective tax rate (%): -2243.7438423645317
Interest coverage ratio: 1.7105413105413108
COGS to revenue (%): 69.71097303316994
SG&A to revenue (%): 10.076914270251141
Free cash flow (dilution-adjusted): 3735036.4963503648
Buyback yield (%): 0.33315303808087904
Retained earnings: -192392700.729927
Inventory turnover: 3.8175548589341695
Receivables turnover: 2.9203063736664543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6685749858265617
FCF margin (%): 5.325714761503315
Rule of 40 score: 5.325714761503315
Financial ratios for DIO.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 747.7727272727273
Shares outstanding: 180410580
Market cap (USD): 134906111435.45454
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIO.DE — annual report dated 2022-12-31
Total revenue: 84237234042.55319
Gross profit: 57654255319.14894
Operating income: 22296808510.638298
Net income: 15640425531.914894
Capital expenditures: 4601063829.787234
Operating cash flow: 18968085106.38298
Depreciation & amortization: 6623404255.319149
Net tangible assets: -30909574468.08511
Owner earnings: 17662765957.446808
Return on net tangible assets (%): -57.14334882120116
Capex to operating income (%): 20.635526504127107
Buffett classification: The Great
Stock price: 673.4787234042554
P/E ratio: 7.76850264457897
Shares outstanding: 180410580
Book value: 57780851063.82979
P/B ratio: 2.102819270917259
Market cap (USD): 121502687107.0213
Debt to equity: 0.6532938100673861
Current ratio: 1.2697558040097552
Quick ratio: 0.6261996009248408
Effective tax rate (%): 26.836186305732486
Interest coverage ratio: 54.72323759791123
COGS to revenue (%): 31.55727870881376
SG&A to revenue (%): 41.9067224025359
Free cash flow (dilution-adjusted): 13560638297.872341
Buyback yield (%): 0
Retained earnings: 6167021276.595745
Inventory turnover: 1.229784930360746
Receivables turnover: 18.596289337717234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.880073322839664
FCF margin (%): 16.098152381192936
Rule of 40 score: 16.098152381192936